Endoscopic Devices - Netherlands

  • Netherlands
  • In the Netherlands, revenue in the Endoscopic Devices market market is projected to reach €291.30m in 2024.
  • The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 7.05%, leading to a market volume of €409.50m by 2029.
  • When compared globally, the highest revenue will be generated the United States, with an expected figure of €9,537.00m in 2024.
  • The Netherlands is experiencing a robust integration of advanced endoscopic devices within its healthcare system, enhancing minimally invasive surgical procedures and patient outcomes.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

The Endoscopic Devices Market in the Netherlands is experiencing moderate growth, influenced by factors such as advancements in minimally invasive procedures, increasing demand for early diagnosis, and enhanced healthcare infrastructure supporting innovative medical technologies.

Customer preferences:
Consumers in the Netherlands are showing a growing preference for minimally invasive surgical options, reflecting a cultural shift towards prioritizing quicker recovery times and less postoperative discomfort. This trend is influenced by an aging population that values efficient healthcare solutions. Additionally, there is an increasing awareness around preventive healthcare, prompting individuals to seek early diagnostic procedures facilitated by advanced endoscopic devices. As health literacy improves, patients are more engaged in their treatment choices, steering demand towards innovative technologies that enhance safety and efficacy.

Trends in the market:
In the Netherlands, the Endoscopic Devices Market is experiencing a notable shift towards advanced imaging technologies and robotic-assisted procedures, enhancing precision in minimally invasive surgeries. This transition is driven by patient demand for quicker recovery and reduced hospital stays, especially among the aging population. Additionally, the rise of preventive healthcare initiatives is encouraging earlier diagnoses, increasing the utilization of endoscopic tools. For industry stakeholders, these trends underscore the importance of investing in innovative technologies and training to meet evolving patient needs and improve surgical outcomes.

Local special circumstances:
In the Netherlands, the Endoscopic Devices Market is influenced by a robust healthcare system characterized by high standards and strict regulatory frameworks. The country's emphasis on patient-centered care fosters a culture prioritizing minimally invasive procedures, aligning with the increasing demand for quicker recovery times. Additionally, the strong presence of innovative healthcare research institutions and partnerships with technology firms facilitates rapid advancements in imaging and robotic-assisted technologies. These local dynamics enhance the market's growth potential and drive the adoption of cutting-edge endoscopic solutions.

Underlying macroeconomic factors:
The Endoscopic Devices Market in the Netherlands is shaped by significant macroeconomic factors, including the nation’s stable economic growth, high healthcare expenditure, and a strong emphasis on innovation. The Dutch government’s fiscal policies support healthcare advancements, promoting investment in medical technologies. Furthermore, the increasing prevalence of chronic diseases and an aging population drive demand for minimally invasive procedures, aligning with global trends towards improved patient outcomes. Additionally, favorable trade agreements and collaboration with international medical technology firms enhance market competitiveness, facilitating the adoption of advanced endoscopic solutions within the healthcare system.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Visión general

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)